Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical StudentsMEDLIPNCT06482476
Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study
An observational study of Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students, run by University of Ioannina at 1 site in Greece.
Trial summary
This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students
- What is being tested?
- Measurement of Lp(a) levels
- How many people
- 246 participants
- Where
- 1 siteGreece
- Study dates
- Jun 2024to Oct 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece
Who may be able to join
- Medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece.
Who cannot join
- Inability/unwillingness to give informed consent
Trial locations and contacts
1 site in 1 country.
Greece1 site, 1 recruiting
- Recruiting
University Hospital of Ioannina
Ioannina, Ioannina, 45000
Fotios Barkas, MD, PhD, +306936636376, f.barkas@uoi.gr
Marios Kourtidis, MD, +306987415932, markourtidis@gmail.com
About this study
Official title: Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study (MEDLIP Study)
This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.
Read the detailed description
Lipoprotein(a) [Lp(a)] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.
- Being tested
- Measurement of Lp(a) levels
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Measurement of Lp(a) levelsDiagnostic test
Collection of a venous blood sample for the measurement of Lp(a) levels using standardized laboratory methods
| Study group | Role | What they receive |
|---|---|---|
| Med students | Medical students in whom Lp(a) levels will be measured Receives: Diagnostic Test: Measurement of Lp(a) levels |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lp(a) elevated
Measured: At time of measurement
Lp(a) beneath cut-off
Measured: At time of measurement
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2024
- Study startJun 2024 (estimated)
- Primary completionJul 2024 (estimated)
- Study completionOct 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical StudentsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 246 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Ioannina
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Fotios Barkas, University of Ioannina
- Investigators
- Fotios Barkas, MD, PhD, Principal investigator, University of Ioannina
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06482476
- Sponsor's protocol ID
- MEDLIP Study
- Acronym
- MEDLIP
- Status last verified
- Jun 2024
- First submitted
- 25 Jun 2024
- Last updated
- 1 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study (MEDLIP Study)
- ClinicalTrials.gov ID
- NCT06482476
- Acronym / sponsor ID
- MEDLIP / MEDLIP Study
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 246 participants (estimated)
- Lead sponsor
- University of IoanninaUniversity, hospital or other
- Study start
- Jun 2024 (estimated)
- Primary completion
- Jul 2024 (estimated)
- Study completion
- Oct 2024 (estimated)
- First posted
- 1 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece. Data collected will include demographic information, family and medical history, as well as lifestyle habits, and the study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students.
Detailed description
Lipoprotein(a) [Lp(a)] has emerged as a prevalent monogenetic cardiovascular risk factor globally. Despite its significance, clinical attention for elevated Lp(a) is suboptimal. This cross-sectional study aims to determine the prevalence of elevated Lp(a) levels among volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece, as well as gather data on the demographic characteristics and medical history of this population. Statistical analysis will assess Lp(a) levels, prevalence, and associations with demographic and cardiovascular risk factors. The study aims to provide valuable insights into the prevalence of elevated Lp(a) among Greek medical students, emphasizing the importance of awareness, early diagnosis, and management of this cardiovascular risk factor.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Med students | – | Diagnostic Test: Measurement of Lp(a) levelsMedical students in whom Lp(a) levels will be measured |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Volunteer medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece
Key inclusion criteria (1 listed)
- Medical students at the Faculty of Medicine, University Hospital of Ioannina, Greece.
Key exclusion criteria (1 listed)
- Inability/unwillingness to give informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Measurement of Lp(a) levelsCollection of a venous blood sample for the measurement of Lp(a) levels using standardized laboratory methods | Diagnostic test | Med students |
Primary outcome
Lp(a) elevated
Time frame: At time of measurement
Lp(a) beneath cut-off
Time frame: At time of measurement
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2024.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fotios Barkas, MD, PhD principal investigator
University of Ioannina
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Insight Into the Prevalence of Elevated Lp(a) Among Greek Medical Students, run by University of Ioannina at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Fotios Barkas, MD, PhD (+306936636376, f.barkas@uoi.gr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lp(a) elevated (time frame: At time of measurement). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024; AzTrials last refreshed its copy on 7 Nov 2026.